Other News To Note
• Dyax Corp., of Burlington, Mass., and Novellus Biopharma AG, of Bogota, Colombia, inked a partnership for the development and commercialization of hereditary angioedema drug Kalbitor (ecallantide) in select regions in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico and Venezuela.